CAS 55778-02-4

1,4-Benzenedimethanamine, N,N'-di-2-pyridinyl-

Description:

1,4-Benzenedimethanamine, N,N'-di-2-pyridinyl- is an organic compound characterized by its structure, which features a benzene ring with two methanamine groups and two pyridine substituents. This compound is classified as an aromatic amine due to the presence of the benzene ring and amine functional groups. It typically exhibits a solid state at room temperature and is soluble in polar organic solvents. The presence of the pyridine rings contributes to its basicity and potential reactivity, making it useful in various chemical applications, including as a ligand in coordination chemistry. Additionally, the compound may exhibit biological activity, which could be of interest in pharmaceutical research. Safety considerations are important, as aromatic amines can pose health risks, including potential carcinogenicity. Proper handling and storage protocols should be followed to mitigate exposure. Overall, 1,4-Benzenedimethanamine, N,N'-di-2-pyridinyl- is a compound of interest in both industrial and research settings due to its unique structural features and potential applications.

Formula: C₁₈H₁₈N₄

Synonyms:

• N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine
• 1,4-benzenedimethanamine, N1,N4-di-2-pyridinyl-
• Wz 811

WZ811

CAS: 55778-02-4

Formula: C₁₈H₁₈N₄

Molecular weight: 290.36

Ref: 7W-GL9514

WZ811

CAS: 55778-02-4

WZ811

Purity: ≥95%

Molecular weight: 290.36g/mol

Ref: 54-BUP10166

WZ811

CAS: 55778-02-4

WZ811 is a novel and effective small molecular CXCR4 antagonist (EC50: 0.3 nM).

Formula: C₁₈H₁₈N₄

Purity: 99.42% - ≥95%

Color and Shape: Solid

Molecular weight: 290.36

Ref: TM-T1739

WZ 811

CAS: 55778-02-4

Formula: C₁₈H₁₈N₄

Purity: >97.0%(T)

Color and Shape: White to Almost white powder to crystal

Molecular weight: 290.37

Ref: 3B-W0017

WZ811

CAS: 55778-02-4

WZ811 is a small-molecule drug that has been shown to have therapeutic effects in a number of autoimmune diseases, such as bowel disease and multiple sclerosis. It binds to chemokine receptors on the surface of immune cells and blocks the binding of chemokines, preventing the release of inflammatory cytokines. WZ811 also prevents neuronal death by inhibiting toll-like receptor 4 (TLR4) signaling pathways. WZ811 has not been tested in humans yet but has shown promising results in vitro assays and in animal models. The compound is being studied for its potential use as a diagnostic agent for brain cancer. This drug has not been tested for toxicity or side effects with regards to HIV infection or other blood disorders.

Formula: C₁₈H₁₈N₄

Purity: Min. 95%

Molecular weight: 290.36 g/mol

Ref: 3D-FCA77802